Originally developed and FDA-approved to treat lipodystrophy (abnormal fat distribution) in HIV patients, Tesamorelin is a GHRH analog that has shown a unique ability to preferentially target visceral adipose tissue
Effect of once-weekly semaglutide on the counterregulatory response to hypoglycaemia in People with type 2 diabetes: a randomized, placebo-controlled, double-blind, crossover trial
For patients with ongoing inflammatory acne together with enlarged pores, Potenza may offer advantages because it addresses both inflammation and structural skin changes
Read the RTW Bio Interim Report for more details about the obesity market: To view or add a comment, sign in 19,432 followers
Dr Kohli is currently practicing as Consultant Internal Medicine at Sitaram Bhartia Institute of Science and Research and Apollo Clinic in East of Kailash
In therapy, we work to accept that were more than our bodies